Sana Biotechnology, Inc. (SANA) Free cash flow 2019–2025
Sana Biotechnology, Inc. (SANA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$144.8MFY2025 · since FY2019: -$111.6M → -$144.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$144.8M | +43.6% |
| FY2024 | -$256.6M | +6.2% |
| FY2023 | -$273.6M | +12.0% |
| FY2022 | -$310.9M | -10.7% |
| FY2021 | -$280.9M | -73.6% |
| FY2020 | -$161.9M | -45.0% |
| FY2019 | -$111.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SANA financial trends
SANA RevenueSANA Net incomeSANA Net marginSANA Gross profitSANA Gross marginSANA Operating incomeSANA Operating marginSANA Operating cash flowSANA Capital expendituresSANA Return on equitySANA Stock buybacksSANA Dividends paidSANA Total assetsSANA Total liabilitiesSANA Shareholders’ equitySANA overview →